Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
CEN Case Reports
Published in: CEN Case Reports 1/2018

01-05-2018 | Case Report

Unexpected delayed bleeding after native renal biopsy: a case report

Authors: Yoichi Takeuchi, Yoshie Ojima, Saeko Kagaya, Satoshi Aoki, Tasuku Nagasawa

Published in: CEN Case Reports | Issue 1/2018

Login to get access

Abstract

Percutaneous native renal biopsy is recognized as a safe procedure. The majority of bleeding events occur within 24 h after the procedure, and reports of delayed major complications are very limited. We report a patient presenting with sudden flank pain 7 days after renal biopsy, in whom abdominal computed tomography showed increased hematoma size with extravasation and who was treated with radiological intervention. Careful attention should be paid to diagnose and treat delayed major complications in patients undergoing native renal biopsy.
Literature
1.
Whittier WL, Korbet SM. Timing of complications in percutaneous renal biopsy. J Am Soc Nephrol. 2004;15:142–7.CrossRefPubMed
2.
Atwell TD, Spanbauer JC, McMenomy BP, Stockland AH, Hesley GK, Schleck CD, Harmsen WS, Welch TJ. The timing and presentation of major hemorrhage after 18,947 image-guided percutaneous biopsies. Am J Roentgenol. 2015;205:190–5.CrossRef
3.
4.
Hogan JJ, Mocanu M, Berns JS. The native kidney biopsy: update and evidence for best practice. Clin J Am Soc Nephrol. 2016;11:354–62.CrossRefPubMed
5.
Tervaert TW, Mooyaart AL, Amann K, Cohen AH, Cook HT, Drachenberg CB, Ferrario F, Fogo AB, Haas M, de Heer E, Joh K, Noël LH, Radhakrishnan J, Seshan SV, Bajema IM, Bruijn JA. Renal Pathology Society. Pathologic classification of diabetic nephropathy. J Am Soc Nephrol. 2010;21:556–63.
6.
Korbet SM. Nephrology and the percutaneous renal biopsy: a procedure in jeopardy of being lost along the way. Clin J Am Soc Nephrol. 2012;7:1545–7.CrossRefPubMed
7.
Tanaka K, Kitagawa M, Onishi A, Yamanari T, Ogawa-Akiyama A, Mise K, Inoue T, Morinaga H, Uchida HA, Sugiyama H, Wada J. Arterial stiffness is an independent risk factor for anemia after percutaneous native kidney biopsy. Kidney Blood Press Res. 2017;42:284–93.CrossRefPubMed
8.
Ishikawa E, Nomura S, Hamaguchi T, Obe T, Inoue-Kiyohara M, Oosugi K, Katayama K, Ito M. Ultrasonography as a predictor of overt bleeding after renal biopsy. Clin Exp Nephrol. 2009;13:325–31.
9.
Simard-Meilleur MC, Troyanov S, Roy L, Dalaire E, Brachemi S. Risk factors and timing of native kidney biopsy complications. Nephron Extra. 2014;4:42–9.CrossRefPubMedPubMedCentral
10.
Nishi S. Series of guidebook of renal biopsy: IV. Prescription of bed-rest after renal biopsy. Nippon Jinzo Gakkai Shi. 2005;47:491–6. (Japanese).PubMed
Metadata
Title
Unexpected delayed bleeding after native renal biopsy: a case report
Authors
Yoichi Takeuchi
Yoshie Ojima
Saeko Kagaya
Satoshi Aoki
Tasuku Nagasawa
Publication date
01-05-2018
Publisher
Springer Japan
Published in
CEN Case Reports / Issue 1/2018
Electronic ISSN: 2192-4449
DOI
https://doi.org/10.1007/s13730-017-0280-3

Other articles of this Issue 1/2018

CEN Case Reports 1/2018 Go to the issue

Case Report

Serum sickness with refractory nephrotic syndrome following treatment with rituximab

Case Report

Advanced native-kidney carcinoma in a heart- and kidney-transplanted patient: a case report

Case Report

Development of hyperkalemia following treatment with dapagliflozin (DAPA) in a patient with type 2 diabetes after bilateral adrenalectomy

Case Report

Renal vein thrombosis complicating severe acute pyelonephritis with renal abscesses and associated bacteraemia caused by extended-spectrum beta-lactamase producing Escherichia coli

Case Report

Xanthogranulomatous pyelonephritis: a case with rare adhesion to pancreas

Case Report

Hemorrhagic shock due to bleeding from an arteriovenous fistula after allograft biopsy in a kidney transplant recipient: a case report
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits